Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

INNOVIVA, INC.

(INVA)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über INNOVIVA, INC.
2021INNOVIVA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
2021Armata Pharmaceuticals Secures $7 Million Investment From Cystic Fibrosis Foundation, I..
2021Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals
2021Armata Pharmaceuticals Inc. announced that it has received $7.000003 million in funding..
2021INNOVIVA, INC. Management's Discussion and Analysis of Financial Condition and Results..
2021Innoviva Reports Third Quarter 2021 Financial Results - Form 8-K
2021Innoviva, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
2021INNOVIVA : Q3 Earnings Snapshot
2021Innoviva Reports Third Quarter 2021 Financial Results
2021Health Care Stocks Pare Early Gains As Cyclicals Dominate Afternoon Trade
2021INNOVIVA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
2021Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on May 20, 2021.
2021INNOVIVA : Q2 Earnings Snapshot
2021INNOVIVA : Reports Second Quarter 2021 Financial Results
2021Innoviva, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021INNOVIVA, INC.(NASDAQGS : INVA) added to Russell 3000 Value Index
2021INNOVIVA, INC.(NASDAQGS : INVA) dropped from Russell 2000 Dynamic Index
2021INNOVIVA, INC.(NASDAQGS : INVA) added to Russell 2000 Value-Defensive Index
2021INNOVIVA, INC.(NASDAQGS : INVA) added to Russell 3000E Value Index
2021INNOVIVA, INC.(NASDAQGS : INVA) added to Russell 2500 Value Index
2021INNOVIVA, INC.(NASDAQGS : INVA) added to Russell Small Cap Comp Value Index
2021INNOVIVA, INC.(NASDAQGS : INVA) added to Russell 2000 Value Index
2021INNOVIVA, INC. : Entry into a Material Definitive Agreement (form 8-K)
2021INNOVIVA : Purchase Agreement (Form 8-K)
2021INNOVIVA : Significant Insider Selling Reported in Shares of Inova Technology (INVA)
2021INSIDER TRENDS : Inova Technology Sees Insider Acquisition Interrupting 90-Days of Sells
2021GlaxoSmithKline Provides Information to Shareholders of Innoviva
2021Innoviva, Inc.'s Equity Buyback announced on May 20, 2021, has closed with 32,005,260 s..
2021INSIDER TRENDS : Inova Technology Insider Prolongs 90-Day Selling Trend
2021GSK : solde sa participation dans Innovia pour 392 M$
2021INNOVIVA, INC. : Entry into a Material Definitive Agreement (form 8-K)
2021INNOVIVA : Announces Strategic Repurchase of GSK's Equity Stake (Form 8-K)
2021INNOVIVA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
2021INNOVIVA : Number of Shares Voted Against or Abstained (Form 8-K)
2021GLAXOSMITHKLINE : GSK Sells Back Entire Stake In Innoviva for $392 Million
2021INNOVIVA : To Buy Back GlaxoSmithKline's Stake For $392 Million
2021Innoviva Buys Back GlaxoSmithKline's Stake for $392 Million
2021STREET COLOR : Innoviva to Repurchase GlaxoSmithKline's 32% Stake in Innoviva for $392 Mln
2021INNOVIVA : Announces Strategic Repurchase of GSK's Equity Stake
2021Innoviva, Inc. announces an Equity Buyback for 32,005,260 shares, representing 32% for ..
2021Innoviva, Inc. authorizes a Buyback Plan.
2021INNOVIVA : Q1 Earnings Snapshot
2021INNOVIVA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
2021Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
2021INNOVIVA : Reports First Quarter 2021 Financial Results
2021Innoviva, Inc. Announce Board Changes
2021Arbitrator Rules Against Theravance Biopharma in Trelegy Royalties Case Against Innovia
2021ARMATA PHARMACEUTICALS : Announces Closing of Second and Final Tranche of $20 Million Priv..
2021INSIDER TRENDS : 90-Day Buying Trend Extended with Insider Purchase of Armata Pharmaceutic..
2021Armata Pharmaceuticals Inc. announced that it has received $20 million in funding from ..
2021INNOVIVA : Former Trump coronavirus coordinator Birx takes job at Texas air purifier maker
2021INNOVIVA, INC. : Change in Directors or Principal Officers (form 8-K)
2021Innoviva, Inc. Appoints Deborah L. Birx to its Board of Directors
2021INNOVIVA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
2021GlaxoSmithKline plc Discloses its Views on Strategic Partnership between Innoviva, Inc ..
2021INNOVIVA : 4Q Earnings Snapshot
2021INNOVIVA : Reports Fourth Quarter 2020 Financial Results
2021Innoviva, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
2021ARMATA PHARMACEUTICALS : Announces $20 Million Investment to Support Advancement of the Co..
2021SECTOR UPDATE : Health Care Stocks Ending Near Wednesday Session Lows
2021SECTOR UPDATE : Health Care Stocks Still on Steep Slide
2021ARMATA PHARMACEUTICALS : to Sell $20 Million in Stock, Warrants to Largest Shareholder
2021Armata Pharmaceuticals Inc. announced that it expects to receive $20 million in funding..
2020Innoviva, Inc. Enters into Strategic Partnership with Sarissa Capital Management LP
2020INNOVIVA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial State..
2020INNOVIVA : Reports Third Quarter 2020 Financial Results
2020INNOVIVA : 3Q Earnings Snapshot
2020Innoviva, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
2020INNOVIVA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
2020INNOVIVA : Reports Third Quarter 2020 Financial Results
2020InCarda Therapeutics, Inc. announced that it expects to receive $62.5 million in fundin..
2020GLAXOSMITHKLINE : FDA approves Trelegy Ellipta as the first once-daily single inhaler trip..
2020INNOVIVA : FDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Ther..
2020Entasis Therapeutics Holdings Inc. announced that it has received $24.999999 million in..
2020ENTASIS THERAPEUTICS : Announces $25 Million Private Placement
1  2  3  4Weiter
Anstehende Termine für INNOVIVA, INC.
10.02.22